NPI: 1194789859 · PEARSALL, TX 78061 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/12/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/12/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 4,034 | $0.00 |
| 2022 | 2,163 | $0.00 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 85048 | 279 | 274 | $0.00 | |
| 83970 | 291 | 265 | $0.00 | |
| 83540 | 233 | 226 | $0.00 | |
| 85041 | 332 | 327 | $0.00 | |
| 82108 | 86 | 85 | $0.00 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 4,238 | 267 | $0.00 |
| A4657 | Syringe, with or without needle, each | 333 | 327 | $0.00 |
| 82728 | 131 | 129 | $0.00 | |
| 83550 | 221 | 214 | $0.00 | |
| 82746 | 13 | 12 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 40 | 25 | $0.00 |